FNH vs Adenoma
- Both are benign liver masses that usually turn up by accident in healthy youngish women — so the question is rarely "is it cancer?" and more "which harmless thing is it, and does it need watching?"
- FNH (focal nodular hyperplasia) is a lump of normal liver tissue that's just disorganized. Its signature is a central scar and the fact that it contains working bile machinery, so it holds onto liver-specific MRI contrast.
- Hepatocellular adenoma is a true tumor of liver cells. It has no bile machinery, so it goes dark on those same delayed liver-specific images — and unlike FNH, it can bleed or (rarely) turn malignant.
- The single most useful test is a hepatobiliary contrast MRI: FNH stays bright on delayed images, adenoma washes out dark. That one frame settles most arguments.
- Adenoma is the one you actually worry about; it's tied to the birth control pill, anabolic steroids, and (for the malignant risk) being large or a specific subtype.
Here's a scenario that happens constantly: a healthy 32-year-old woman gets a scan for a kicked-shin or a kidney stone, and the report comes back with a surprise liver lump nobody was looking for. Now everyone's a little tense. The good news is that the two usual suspects — focal nodular hyperplasia (FNH) and hepatocellular adenoma — are both benign. The whole game is telling these two friendly-looking strangers apart, because one of them you can basically forget about, and the other you keep an eye on.
Two very different origin stories
Think of the liver as a well-run city, with roads (blood vessels) and a plumbing system (bile ducts) all laid out in a tidy grid.
FNH is that same city, just with a confused city planner. All the right buildings are there — real liver cells, real bile plumbing, real blood supply — they're just arranged in a chaotic swirl around a central roundabout. That roundabout is the famous central scar: a star of fibrous tissue with a feeding artery in the middle. Crucially, because FNH contains genuine working bile machinery, it behaves like real liver tissue in ways we can exploit.
An adenoma is a brand-new building put up by a rogue developer. It's a real tumor — a clonal overgrowth of liver cells (hepatocytes) — but it skipped the permits. There's no organized bile plumbing inside it, and its blood vessels are flimsy and prone to springing leaks. That missing plumbing and that fragile blood supply are the entire reason adenomas behave differently, and more dangerously, than FNH.
The trick that cracks the case: hepatobiliary MRI
If you remember one thing, make it this. On a regular contrast scan, both lesions light up briskly in the arterial phase (they're vascular) and can look frustratingly similar. The tiebreaker is a special MRI done with a hepatobiliary contrast agent — a gadolinium dye that healthy liver cells suck up and dump into bile, then we image late, after the dye has cleared from generic tissue.
The logic is almost too neat. FNH has working bile machinery, so on those delayed hepatobiliary-phase images it stays bright (it grabbed the dye and has nowhere to dump it). An adenoma has no functioning bile plumbing, so it lets the dye wash out and goes dark. Same dye, opposite behavior — that contrast is the punchline.
One honest caveat to the "adenoma always washes out" rule: the inflammatory subtype of adenoma can hold onto hepatobiliary contrast and stay iso- to hyperintense, mimicking FNH on that one frame. So treat the delayed image as a powerful tilt toward FNH when a lesion stays bright, not an absolute lock — and let the whole picture, plus the clinical history, vote.
The central scar: helpful, but not a lie detector
FNH's calling card is the central scar, and on MRI it has a classic look: dark on T1, bright on T2, with delayed enhancement (the fibrous scar soaks up dye slowly and holds it). When you see a central scar in a young woman's liver mass, FNH should jump to the front of the line.
Don't treat the scar as a guarantee. A "central scar" can also show up in other lesions — including the fibrolamellar variant of liver cancer, whose scar tends to be dark on T2 rather than bright. The scar is a strong hint toward FNH, not a stamped certificate. Read it alongside everything else.
Why adenoma is the one that keeps you up at night
FNH is essentially a benign curiosity — it doesn't bleed dangerously and it doesn't turn into cancer, so once you're confident, you can usually leave it alone.
Adenoma is different, and this is where the clinical history earns its keep. Adenomas are linked to oral contraceptive pills, anabolic steroid use, and pregnancy hormones. Two things make them worth respecting:
| Feature | FNH | Hepatocellular adenoma |
|---|---|---|
| What it is | Disorganized normal liver tissue | True benign tumor of liver cells |
| Central scar | Often present (T2 bright) | Usually absent |
| Hepatobiliary-phase MRI | Stays bright (retains contrast) | Goes dark (washes out) |
| Risk of bleeding | Negligible | Real, especially when large |
| Malignant potential | None | Small but real (subtype-dependent) |
| Typical management | Reassure, often no follow-up | Stop hormones; watch, resect if large |
A common threshold worth knowing: larger adenomas (often cited around the 5 cm mark) carry enough bleeding and malignant-transformation risk that surgeons start thinking about removing them, whereas smaller ones may just be watched after stopping the offending hormones. Confirm the exact cutoff against current guidance — it's a judgment call, not a magic number.
How this fits the bigger liver-lesion picture
Both of these live in the broader world of focal liver lesions, where your first job is always to separate the benign crowd (FNH, adenoma, and the ever-popular hemangioma) from the genuinely scary one, hepatocellular carcinoma. The reassuring part: HCC almost always shows up in a chronically damaged, cirrhotic liver, while FNH and adenoma turn up in otherwise healthy ones. The background liver is half the diagnosis.
So when that incidental lump appears: check who the patient is and what their liver looks like, hunt for a central scar, and — when it matters — get the hepatobiliary MRI and watch which lesion keeps the dye. FNH holds on; adenoma lets go. Get that one frame, and most of the tension in the room evaporates.